Dronabinol Versus Standard Ondansetron Antiemetic Therapy in Preventing Delayed-Onset Chemotherapy-Induced Nausea and Vomiting
Public ClinicalTrials.gov record NCT00642512. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Efficacy Study of Oral Dronabinol Alone and in Combination With Ondansetron Versus Ondansetron Alone in Subjects With Delayed Chemotherapy-Induced Nausea and Vomiting
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary purpose of the study is to determine the efficacy of oral dronabinol versus standard ondansetron antiemetic therapy in preventing delayed-onset chemotherapy-induced nausea and vomiting (CINV) or retching by measuring the incidence of total response of nausea and vomiting and/or retching following administration of moderate-to-high emetogenic chemotherapeutic agents.
Study identification
- NCT ID
- NCT00642512
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 64 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 2003 (Type not available)
- Primary completion
- Jul 2004 (Actual)
- Completion
- Jul 2004 (Actual)
- Last update posted
- Apr 3, 2008
2003 – 2004
United States locations
- U.S. sites
- 43
- U.S. states
- 22
- U.S. cities
- 40
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Site 970 | Tucson | Arizona | — | — |
| Site 950 | Anaheim | California | — | — |
| Site 925 | Fountain Valley | California | — | — |
| Site 913 | Greenbrae | California | — | — |
| Site 909 | Los Angeles | California | — | — |
| Site 908 | Pomona | California | — | — |
| Site 943 | Rancho Mirage | California | — | — |
| Site 932 | Boynton Beach | Florida | — | — |
| Site 924 | Hollywood | Florida | — | — |
| Site 940 | Lakeland | Florida | — | — |
| Site 921 | New Port Richey | Florida | — | — |
| Site 929 | New Port Richey | Florida | — | — |
| Site 933 | Ormond Beach | Florida | — | — |
| Site 922 | Marietta | Georgia | — | — |
| Site 928 | Harvey | Illinois | — | — |
| Site 914 | Orland Park | Illinois | — | — |
| Site 926 | Skokie | Illinois | — | — |
| Site 946 | Springfield | Illinois | — | — |
| Site 956 | Terre Haute | Indiana | — | — |
| Site 905 | Southfield | Michigan | — | — |
| Site 916 | Fergus Falls | Minnesota | — | — |
| Site 937 | Greenwood | Mississippi | — | — |
| Site 958 | St Louis | Missouri | — | — |
| Site 904 | Missoula | Montana | — | — |
| Site 919 | Little Silver | New Jersey | — | — |
| Site 920 | Voorhees Township | New Jersey | — | — |
| Site 948 | Brooklyn | New York | — | — |
| Site 953 | Brooklyn | New York | — | — |
| Site 910 | The Bronx | New York | — | — |
| Site 949 | Valhalla | New York | — | — |
| Site 947 | Wilmington | North Carolina | — | — |
| Site 902 | Bismarck | North Dakota | — | — |
| Site 942 | Fargo | North Dakota | — | — |
| Site 944 | Columbus | Ohio | — | — |
| Site 934 | Oklahoma City | Oklahoma | — | — |
| Site 931 | Philadelphia | Pennsylvania | — | — |
| Site 906 | Pittsburgh | Pennsylvania | — | — |
| Site 918 | Charleston | South Carolina | — | — |
| Site 923 | North Charleston | South Carolina | — | — |
| Site 917 | Chattanooga | Tennessee | — | — |
| Site 939 | Chattanooga | Tennessee | — | — |
| Site 915 | Texarkana | Texas | — | — |
| Site 951 | Arlington | Virginia | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00642512, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 3, 2008 · Synced Oct 27, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00642512 live on ClinicalTrials.gov.